BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
10.34
+0.37 (3.71%)
At close: May 12, 2025, 4:00 PM
10.40
+0.06 (0.58%)
After-hours: May 12, 2025, 7:31 PM EDT
BioCryst Pharmaceuticals Employees
BioCryst Pharmaceuticals had 580 employees as of December 31, 2024. The number of employees increased by 44 or 8.21% compared to the previous year.
Employees
580
Change (1Y)
44
Growth (1Y)
8.21%
Revenue / Employee
$868,078
Profits / Employee
-$92,190
Market Cap
2.16B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BCRX News
- 7 days ago - BioCryst Pharmaceuticals Soars 23% In One Session - Here's Why It Surprised Investors - Benzinga
- 7 days ago - BioCryst: Strong Opportunity For A Double With A Proven Therapy - Seeking Alpha
- 7 days ago - BioCryst Pharmaceuticals, Inc. (BCRX) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - BioCryst Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 10 days ago - BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 11 days ago - BioCryst Appoints Steve Frank to Board of Directors - GlobeNewsWire
- 12 days ago - BioCryst to Present at Upcoming Investor Conferences - GlobeNewsWire
- 21 days ago - BioCryst to Report First Quarter 2025 Financial Results on May 5 - GlobeNewsWire